Outcome of Cervical Lymph Nodes Dissection for Thyroid Cancer with Nodal Metastases: A Southeast Asian 3-Year Experience
Table 1
Patients’ demographic characteristics.
Characteristic
Type of Lymph Node Dissection, N (%)
CND, n=8
LND, n=15
BOTH, n=20
Age, mean (SD), in years
44.75 (16.4)
52.53 (12.4)
49.7 (16.3)
Gender
Male, n = 18 (41.9)
3 (16.7)
10 (55.6)
5 (27.8)
Female, n= 25 (58.1)
5 (20.0)
5 (20.0)
15 (60.0)
TNM Staging
I, n=12 (27.9)
4 (33.3)
2 (16.7)
6 (50.0)
II, n=2 (4.7)
0 (0.0)
1 (50.0)
1 (50.0)
III, n=1 (2.3)
1 (100.0)
0 (0.0)
0 (0.0)
IVa, n=21 (48.8)
2 (9.5)
9 (42.9)
10 (47.6)
IVb, n=4 (9.3)
0 (0.0)
3 (75.0)
1 (25.0)
IVc, n=3 (7.0)
1 (33.3)
0 (0.0)
2 (66.7)
Extra Cervical Metastases upon presentation
2 (33.3)
1 (16.7)
3 (50.0)
RAI Ablation
6 (20.0)
11 (36.7)
13 (43.3)
Radiotherapy
0 (0.0)
4 (50.0)
4 (50.0)
Chemotherapy
0 (0.0)
2 (50.0)
2 (50.0)
Abbreviations: RAI Ablation, Radioactive 131Iodine Ablation; CND, central neck dissection; LND, lateral neck dissection; BOTH, both central and lateral neck dissection. TNM staging is based on American Joint Committee for Cancer (AJCC) Cancer Staging Manual Seventh Edition [6].
